Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 2:56 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
View Ticker Page (AVII)
Results 1 - 10 of 20 : 12
Recs
Arpeggio4u (67.80) Submitted: 11/07/06 7:59 AM : Start Price: $3.90 AVII Score: -42.91
Look for future (2-6 months) in there revamp of their Hepatitis B trial to provide for volatility. Success will solidify this as a near future player and push the stock into the 12-15 dollar range short term wether it deserves to be there or not. L...
Report this Post Replies: 1 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
PiedMoose (68.99) Submitted: 8/24/06 11:32 PM : Start Price: $3.28 AVII Score: -46.02
AVII has 6+ compounds in preclinical and clinical trials, for targets including Hepatitis C, Restenosis, Ebola, and Muscular Dystrophy. They own and develop a unique technology that can be quickly developed for new targets. The company has the pote...
Report this Post Replies: 4 | Reply | Permalink
StrategyGuru (< 20) Submitted: 10/22/07 9:14 AM : Start Price: $2.82 AVII Score: -27.84
This company recently changed it's management team and has made progress in obtaining govt. work. As with many companies, growing the federal allotment of funds provides stability & cashflow to accelerate growth. Look for federal funds to increase ...
Report this Post Replies: 0 | Reply | Permalink
em5 (< 20) Submitted: 2/11/07 6:20 PM : Start Price: $2.93 AVII Score: -31.41
Aiming towards some pretty big markets .At the moment though, still slogging it's way through ph I/II trials and anyone who follows Pharma or biotech knows that 90% of new drugs end up down the drain. I'm not letting that little fact deter me from th...
zzlangerhans (98.53) Submitted: 11/24/07 6:01 AM : Start Price: $2.50 AVII Score: -25.14
I'm not confident enough in this pick to buy it in real life, but I'm trying to increase my CAPS volume and I'm running out of small cap biotechs. Basically, it seems that AVI has too much going on for a 128M market cap. The flipside is that it could...
bzshadow (< 20) Submitted: 11/22/06 12:02 PM : Start Price: $3.76 AVII Score: -40.64
speculative early stage biotech but leader in third generation antisense. ran up early last year but then sold off on early trial result for hep c. has potential to explode to upside and pretty good technology.
lowcapnocap (37.45) Submitted: 9/14/06 9:12 PM : Start Price: $3.60 AVII Score: -43.74
government contracts...need i say more!
martin7548 (< 20) Submitted: 8/24/06 12:38 AM : Start Price: $3.87 AVII Score: -47.04
This will be affected by the flu season this winter.
closetdoor (93.62) Submitted: 9/27/06 5:08 PM : Start Price: $3.57 AVII Score: -42.70
This is speculative but I think it will do well in the near future.
audiowhore (34.84) Submitted: 5/08/07 6:21 AM : Start Price: $3.04 AVII Score: -29.75
just picked up a few shares monday for 3.05 a share on the basis the D.O.D. gave them a VERY SMALL chunk of change, I think just barely above $7mil to develope some homeland security vacines. The 52 wk high is more than double the current price. bl...
Terms & Conditions
RSS Headlines
Fool UK